Global Real-time PCR (qPCR) and Digital PCR (dPCR) Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Real-time PCR (qPCR) and Digital PCR (dPCR) Market Research Report 2024
Real-time PCR or quantitative PCR is a well-established technology that has become the tool of choice for the rapid, sensitive quantification of nucleic acid in various biological samples. qPCR measures the accumulation of DNA during a PCR reaction. The increase in quantity of DNA at each cycle is measured by the change in intensity of a fluorescent signal. Comparison to a reference sample determines the number of original copies of template DNA in the reaction.Digital PCR is a highly precise approach to sensitive nucleic acid detection and quantification. Each sample is partitioned into thousands of individual reactions (droplets for Droplet Digital™ PCR technology). Each partition is analyzed after end-point PCR cycling for the presence or absence of a fluorescent signal, and the absolute number of molecules present in the sample is calculated. dPCR does not require a standard curve for quantification.Both quantitative PCR (qPCR) and digital PCR (dPCR) provide sensitive and specific detection, and precise quantification of nucleic acids. Both technologies have similarities, but they have differences that make one or the other the more adapted choice for specific applications.
According to MRAResearch’s new survey, global Real-time PCR (qPCR) and Digital PCR (dPCR) market is projected to reach US$ 1967.4 million in 2033, increasing from US$ 1315 million in 2022, with the CAGR of 5.8% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Real-time PCR (qPCR) and Digital PCR (dPCR) market research.
Global Digital PCR (DPCR) and QPCR key players include Thermo Fisher, Roche, QIAGEN, Bio-rad, Agilent, etc. Global top five manufacturers hold a share about 75%.
North America is the largest market, with a share about 50%, followed by Europe and China, both have a share about 40 percent.
In terms of product, qPCR is the largest segment, with a share about 70%. And in terms of application, the largest application is Research Use, followed by Clinical Use.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Real-time PCR (qPCR) and Digital PCR (dPCR) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Thermo Fisher
Bio-rad
Segment by Type
Digital Microfluidic Chip PCR
Droplet Digital PCR
Medical Institutions
Universities and Research Institutes
Government
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Real-time PCR (qPCR) and Digital PCR (dPCR) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Real-time PCR (qPCR) and Digital PCR (dPCR) market is projected to reach US$ 1967.4 million in 2033, increasing from US$ 1315 million in 2022, with the CAGR of 5.8% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Real-time PCR (qPCR) and Digital PCR (dPCR) market research.
Global Digital PCR (DPCR) and QPCR key players include Thermo Fisher, Roche, QIAGEN, Bio-rad, Agilent, etc. Global top five manufacturers hold a share about 75%.
North America is the largest market, with a share about 50%, followed by Europe and China, both have a share about 40 percent.
In terms of product, qPCR is the largest segment, with a share about 70%. And in terms of application, the largest application is Research Use, followed by Clinical Use.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Real-time PCR (qPCR) and Digital PCR (dPCR) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher
Bio-rad
Segment by Type
Digital Microfluidic Chip PCR
Droplet Digital PCR
Segment by Application
Medical Institutions
Universities and Research Institutes
Government
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Real-time PCR (qPCR) and Digital PCR (dPCR) report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices